FGFR2 and neoplasm: The CTNNB1-mutant (p.I35T) tumor in our series was morphologically distinct, displaying more fibrous stroma, focal glandular differentiation, less primitive cytologic features, a lower mitotic rate, and a lower Ki-67 proliferative index compared to the FGFR2-mutant tumors.